Pathogenica, Illumina to Co-Market HAI BioDetection Kit on MiSeq | GenomeWeb

NEW YORK (GenomeWeb News) – Pathogenica said today that it will co-market with Illumina a new version of its HAI BioDetection kit on Illumina's MiSeq desktop sequencing system in the Asia Pacific region.

The new version of the kit, which uses targeted next-generation sequencing to detect bacterial strains involved in hospital acquired infections, will enable users to identify an expanded panel of bacteria and drug-resistant genes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.